The largest disparities were in the use of the new colorectal and lung cancer drugs: bevacizumab, cetuximab, erlotinib and pemetrexed, the study found.
3
结论直肠癌淋巴结转移状态对RERC和LC淋巴结内药物浓度聚集无明显影响。
Conclusion Tumor metastasis status of rectal cancer lymph nodes exerts insignificant effect on drug concentration for LC and RERC.